Portfolio company
HighLife Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
HighLife Medical develops transcatheter mitral valve replacement systems for patients suffering from moderate to severe mitral regurgitation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
JenaValve
This medical device company develops transcatheter heart valve replacement systems for patients suffering from symptomatic aortic regurgitation and aortic stenosis.
Lifelet Medical
Lifelet Medical develops synthetic polymer heart valve replacements for patients with heart valve disease to replace animal-tissue-based solutions.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.